Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 14;14(3):383.
doi: 10.3390/life14030383.

Unusual and Unconsidered Mechanisms of Bacterial Resilience and Resistance to Quinolones

Affiliations
Review

Unusual and Unconsidered Mechanisms of Bacterial Resilience and Resistance to Quinolones

Joaquim Ruiz. Life (Basel). .

Abstract

Quinolone resistance has been largely related to the presence of specific point mutations in chromosomal targets, with an accessory role of impaired uptake and enhanced pump-out. Meanwhile the relevance of transferable mechanisms of resistance able to protect the target of pump-out or inactivate quinolones has been increasingly reported since 1998. Nevertheless, bacteria have other strategies and mechanisms allowing them to survive and even proliferate in the presence of quinolones, which might be qualified as resistance or resilience mechanisms. These include decreasing levels of quinolone target production, transient amoeba protection, benthonic lifestyle, nutrient-independent slow growth, activation of stringent response, inactivation or degradation of quinolones as well as apparently unrelated or forgotten chromosomal mutations. These mechanisms have been largely overlooked, either because of the use of classical approaches to antibiotic resistance determination or due to the low increase in final minimum inhibitory concentration levels. This article is devoted to a review of a series of these mechanisms.

Keywords: RNA polymerase mutation; amoeba; biofilm; quinolone targets; quinolones inactivation; stringent response; toxin/antitoxin systems.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Subclasses of quinolones. At present, 4 subclasses of quinolones (A) quinolines; (B) cinnolines; (C) Pyridopyrimidine; (D) Naphthyridine have been described; atom numeration is described following the quinolines (A) structure, with position 1 risen in the nitrogen atom. The figure also illustrates the structure of 2-Pyridons (E), because they are structurally related, but at present, none have been introduced in human or veterinary practice. Reproduced from reference [1], with permission from the American Society of Microbiology.
Figure 2
Figure 2
Proposed model of independent action of stringent and toxin/antitoxin systems. TA: Toxin/antitoxin system; QS: Quorum sensing; SS: Secretion systems; ROS. Reactive Oxygen Species; T3SS: Type 3 secretion systems. (A) Molecular mechanisms underlying bacterial persistence. (B) Different models explaining the involvement of (p)ppGpp in persistence and representative publications (see reference [135]). (B) red: T/A systems are activated by (p)ppGpp. grey: T/A systems induce quiescence independently; light green: (p)ppGpp protects against oxidative stress, favoring the development of persister cells; dark green: (p)ppGpp induces dimerization of ribosomes, which subsequently lead to persistence. References presents in the figure may be found at [138]. Reproduced from reference [138], with the permission of Elsevier.
Figure 3
Figure 3
Models of development of persister cells. Note that while all pathways are represented as independent routes, different interactions among them may be present. Reproduced from reference [142], published under a Creative Commons license.
Figure 4
Figure 4
Proposed network of metabolites generated from ciprofloxacin by the brown rot fungus Gloeophyllum striatum. (A) Oxidative decarboxylation. (B) Defluorination. (C) Hydroxylation at C-8. (D) Oxidation of the amino moiety. Trace metabolites, detected only by HPLC–MS are represented at a reduced size. Reproduced from reference [158], with the permission of Elsevier.
Figure 5
Figure 5
Effect of glnA on the susceptibility levels to norfloxacin. Norfloxacin disk assay of non-induced (gray bars) and IPTG-induced (white bars) cultures of E. coli BL21(DE3) pLysS containing plasmids with or without the glnA insert. In the cells with the glnA insert, the reduced diameter of the clear zones of inhibition due to induction of glutamine synthetase was statistically significant (p < 0.05). Reproduced from reference [168] with the permission of Elsevier.

Similar articles

Cited by

References

    1. Ruiz J. Transferable mechanisms of quinolone resistance from 1998 onward. Clin. Microbiol. Rev. 2019;32:e00007-19. doi: 10.1128/CMR.00007-19. - DOI - PMC - PubMed
    1. Correia S., Poeta P., Hébraud M., Capelo J.L., Igrejas G. Mechanisms of quinolone action and resistance: Where do we stand? J. Med. Microbiol. 2017;66:551–559. doi: 10.1099/jmm.0.000475. - DOI - PubMed
    1. Hooper D.C., Jacoby G.A. Topoisomerase Inhibitors: Fluoroquinolone mechanisms of action and resistance. Cold Spring Harb. Perspect. Med. 2016;6:a025320. doi: 10.1101/cshperspect.a025320. - DOI - PMC - PubMed
    1. Pohlhaus J.R., Kreuzer K.N. Norfloxacin-induced DNA gyrase cleavage complexes block Escherichia coli replication forks, causing double-stranded breaks in vivo. Mol. Microbiol. 2005;56:1416–1429. doi: 10.1111/j.1365-2958.2005.04638.x. - DOI - PMC - PubMed
    1. Barton N., Crowther A.F., Hepworth W., Richardson N.D., Driver G.W. New Quinolones and Therapeutic Compositions Containing Them. 830832. British Patent. 1960 March 23;

LinkOut - more resources